CD4 rate of increase is preferred to CD4 threshold for predicting outcomes among virologically suppressed HIV-infected adults on antiretroviral therapy. by Sol Aldrete, Jeong Hoon Jang, Kirk A Easley, Jason Okulicz, Tian Dai, Yi No Chen, Maria Pino, Brian K Agan, Ryan C Maves, Mirko Paiardini, Vincent C Marconi

Get full text

A worldwide look into long COVID-19 management: an END-COVID survey by Mattia Nigro, Claudia Valenzuela, Francisco Arancibia, Mark Cohen, David C.L. Lam, Ryan C. Maves, Barbara Rath, Steven Q. Simpson, Yuanlin Song, Sotirios Tsiodras, James D. Chalmers, Stefano Aliberti

Get full text

Performance Analysis of the National Early Warning Score and Modified Early Warning Score in the Adaptive COVID-19 Treatment Trial Cohort by Christopher J. Colombo, MD, MA, FACP, FCCM, Rhonda E. Colombo, MD, MHS, FACP, FIDSA, Ryan C. Maves, MD, FCCM, FCCP, FIDSA, Angela R. Branche, MD, Stuart H. Cohen, MD, Marie-Carmelle Elie, MD, Sarah L. George, MD, Hannah J. Jang, PhD, RN, CNL, PHN, Andre C. Kalil, MD, MPH, David A. Lindholm, MD, FACP, Richard A. Mularski, MD, MSHS, MCR, ATSF, FCCP, FACP, Justin R. Ortiz, MD, MS, FACP, FCCP, Victor Tapson, MD, C. Jason Liang, PhD, On behalf of the ACTT-1 Study Group

Get full text